A Validated stability-indicating reverse phase hplc assay method for the determination of memantine hydrochloride drug substance with UV-detection using precolumn derivatization technique

Analytical Chemistry Insights

Volumn 2010, Issue 5, 2010, Pages 37-45

  Narola, Bhavil ^a   Singh, A S ^a   Santhakumar, P Rita ^a   Chandrashekhar, T G ^a  

^a RANBAXY RESEARCH LABORATORIES   (India)

Author keywords

Assay; FMOC; HPLC; Memantine hydrochloride; Precolumn derivatization

Indexed keywords

EID: 77955034429     PISSN: None     EISSN: 11773901     Source Type: Journal    
DOI: 10.4137/aci.s3936     Document Type: Article

References (26)

1. Schneider E, Fischer PA, Clemens R, Balzereit EW, Funfgeld HJ. Effects of oral memantine administration on Parkinson symptoms. Results of a placebocontrolled multicenter study. Dtsch Med Wschr. 1984;109:987-90.
2. Ditzler K. Efficacy and tolerability of memantine in patients with dementia syndrome. Arzneim Dorch/Drug Res. 1991;41:773-80.
3. Kornhuber J, Weller M, Schoppmeyer K, Riederer P. Amantadine and Memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm Suppl. 1994;43:91-104.
4. Gortelmeyer R, Pantev M, Parsons CG, Quack G. Memantine in the treatment of mild to moderate dementia syndrome. Kvon, 'Wild (Ed.) Spektrum der Neurorehabilitation W. Zuckschwerdt Verlag Munchen. 1993;50-6.
5. Herman BH, Vocci F, Bridge P. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction. Neuropsychopharmacology. 1995;13:269-93.
6. Stephens DN. A glutamatergic hypothesis of drug dependence: extrapolations from benzodiazepine receptor ligands. Behav Pharmacol. 1995; 6:425-46.
7. Trujillo KA. Effects of Noncompetitive N-Methyl-d-Aspartate Receptor Antagonists on Opiate Tolerance and Physical Dependence. Neuropsychopharmacology. 1995;13:301-7.
8. Elliott KJ, Brodsky M, Hynansky KM, Inturrisi CE. Dextromethorphan shows efficacy in experimental pain (nociception) and opioid tolerance. Neurology. 1995;45:S66-8.
9. Kalivas PW. Can EAA transmission play a ubiquitous role in drug-induced neural plasticity? Commentary on Stephens, 'A glutamatergic hypothesis of drug dependence: extrapolations from benzodiazepine receptor ligands'. Behav Pharmacol. 1995;6:452-4.
10. Rabey JM, Nissipeanu P, Korczyn AD. Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease. J Neural Transm Park Dis Dement Sect. 1992;4:277-82.
11. Reiderer P, Lange KW, Kornhuber J, Danielczyk W. Pharmacotoxic psychosis after memantine in Parkinson's disease. Lancet. 1991;338:1022-3.
12. Suckow RF. Separation methods for tricyclic antiviral drugs. J Chromatogr B. 2001;764:313-25.
13. Iwata T, Fujino H, Sonoda J, Yamaguchi M. Determination of Amantadine in Human Plasma by High-Performance Liquid Chromatography with Fluorescence Detection. Anal Sci. 1997;13:467-70.
14. Suckow RF, Zhang MF, Collins ED, Fischman MW, Cooper TB. Sensitive and selective liquid chromatographic assay of memantine in plasma with fluorescence detection after pre-column derivatization. J Chromatogr B. 1999;729:217-24.
15. Zhou FX, Krull IS, Feibush BJ. Direct determination of adamantanamine in plasma and urine with automated solid phase derivatization. J Chromatogr B. 1993;619:93-101.
16. Reichova N, Pazourek J, Polaskova P, Havel J. Electrophoretic behavior of adamantane derivatives possessing antiviral activity and their determination by capillary zone electrophoresis with indirect detection. Electrophoresis. 2002;23:259-62.
17. Belanger PM, Grechbelanger O. Gas-liquid chromatographic determination of plasma and urinary levels of amantadine in man. J Chromatogr B. 1982;228:327-32.
18. Bleidner WE, Harmon JB, Hewes WE, Lynes TE, Herman EC. Absorption, distribution and excretion of amantadine hydrochloride. J Pharmacol Exp Ther. 1965;150:484-90.
19. Stumph MJ, Noall MW, Knight V. Gas-chromatographic determination of amantadine in human urine. Clin Chem. 1980;26:295-6.
20. Wesemann W, Schollmeyer JD, Sturm G. Gaschromatographic and mass spectrometric studies on metabolites of adamantane amines excreted with urine. Arzneim Forch. 1977;27(II):1471-7.
21. Biandrate P, Tognoni G, Belvedere G, Frigerio A, Rizzo AM, Morselli PL. A gas chromatographic method for the determination of amantadine in human plasma. J Chromatogr. 1972;74:31-4.
22. Fukuda EK, Rodriguez LC, Choma N, Keigher N, Degrazia F, Garland WA. Quantitative determination of rimantadine in human plasma and urine by GC-MS. Biomed. Environ. Mas Spectom. 1987;14:549-53.
23. Rake SD. Determination of amantadine in human plasma by capillary gas chromatography using electron-capture detection following derivatization with pentafluorobenzoyl chloride. J Pharm Biomed Anal. 1993;11:699-703.
24. Sioufi A, Pommier F. Gas chromatographic determination of amantadine hydrochloride (symmetrel) in human plasma and urine. J Chromatogr B. 1980;183:33-9.
25. Zhou FX, Krull IS, Feibush B. Direct determination of adamantanamine in plasma and urine with automated solid phase derivatization. J Chromatogr. 1993;619:93-101.
26. Lingeman H, Underberg WJM, Takadate A, Hulshoff A. Fluorescence Detection in High Performance Liquid Chromatography. J Liquid Chrom and Related Tech. 1985;8:789-874.